Arkios BioDevelopment International

Founded in 1993 by Dr. Gary Pekoe, Arkios provides product development services for emerging technology companies in the biopharmaceutical industry. Clients in the emerging technology arena require focused, hands-on, reliable service the first time. We provide that to each and every client. The background of our people includes strong start-up biot... echnology company experience, which means we understand the culture and environment of an emerging company. We understand terms like "burn rate," and know the importance of hitting corporate as well as developmental milestones. Arkios is divided into three functional areas: Early Stage Product Development Services, Phase I services, and Phase II-IV Clinical Trial Management. Our Early Stage group conceives Strategic Regulatory Plans, develops and manages preclinical / pre-IND programs, writes and files INDs, and manages Phase I trials for our clients. Our new Phase I center in Virginia Beach is designed to provide top quality bioavailability/bioequivalence studies for clients in need of Phase I service. In the Phase II-IV group, we provide full CRO services such as Clinical Trial Design & Management, Monitoring / Quality Assurance, full Regulatory Affairs consulting including ANDAs, Data Management, Biostatistics, Medical Writing, Investigator Location, and other tasks related to clinical product development. Items from this list are also available in a piecemeal consulting fashion.Read More